Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Albireo Pharma (ALBO)
NASDAQ:ALBO
Albireo Pharma (ALBO) Stock Price & Analysis
0 Followers
ALBO Stock Chart & Stats
Day’s Range$43.99 - $44.9
52-Week Range― - ―
Previous Close$44.25
Volume1.24M
Average Volume (3M)N/A
Market Cap
915.89M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,744,886
10 Day Avg. Volume457,357
30 Day Avg. Volume703,772
Standard Deviation0.19
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)10.95
Price to Sales (P/S)36.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-8.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$43.80Price Target Upside-0.79% Downside
Rating ConsensusHold
Number of Analyst Covering6
Albireo Pharma News
Market NewsAlbireo Sells Out to Ipsen
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALBO FAQ
What was Albireo Pharma’s price range in the past 12 months?
Currently, no data Available
What is Albireo Pharma’s market cap?
Currently, no data Available
When is Albireo Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Albireo Pharma’s earnings last quarter?
Currently, no data Available
Is Albireo Pharma overvalued?
According to Wall Street analysts Albireo Pharma’s price is currently Overvalued.
Does Albireo Pharma pay dividends?
Albireo Pharma does not currently pay dividends.
What is Albireo Pharma’s EPS estimate?
Albireo Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Albireo Pharma have?
Currently, no data Available
What happened to Albireo Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Albireo Pharma?
Among the largest hedge funds holding Albireo Pharma’s share is Perceptive Advisors LLC. It holds Albireo Pharma’s shares valued at 38M.
---
Albireo Pharma Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Albireo Pharma
Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---